ABICOMP Trademark

Trademark Overview

On Thursday, August 8, 2019, a trademark application was filed for ABICOMP with the United States Patent and Trademark Office. The USPTO has given the ABICOMP trademark a serial number of 88572344. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 25, 2023. This trademark is owned by Omeros Corporation. The ABICOMP trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Medical information services, namely, providing information concerning pharmaceutical and biopharmaceutical products, and therapeutic methods in the fields of endothelial diseases and disorders, renal diseases, transplant complications, ischemia reperfusion injury, hematological, autoimmune, immunological and inflammatory related diseases and disorders

Research and development in the pharmaceutical and biotechnology fields; providing medical and scientific research information in the fields of pharmaceuticals and biopharmaceuticals
abicomp

General Information

Serial Number88572344
Word MarkABICOMP
Filing DateThursday, August 8, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 25, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 30, 2020

Trademark Statements

Goods and ServicesMedical information services, namely, providing information concerning pharmaceutical and biopharmaceutical products, and therapeutic methods in the fields of endothelial diseases and disorders, renal diseases, transplant complications, ischemia reperfusion injury, hematological, autoimmune, immunological and inflammatory related diseases and disorders
Goods and ServicesResearch and development in the pharmaceutical and biotechnology fields; providing medical and scientific research information in the fields of pharmaceuticals and biopharmaceuticals

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, August 26, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, May 13, 2020
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOmeros Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeattle, WA 98119
Party NameOmeros Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98119

Trademark Events

Event DateEvent Description
Monday, September 25, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 25, 2023ABANDONMENT - NO USE STATEMENT FILED
Wednesday, March 1, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 28, 2023SOU EXTENSION 5 GRANTED
Friday, February 10, 2023SOU EXTENSION 5 FILED
Tuesday, February 28, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, February 10, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, August 17, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 15, 2022SOU EXTENSION 4 GRANTED
Monday, August 15, 2022SOU EXTENSION 4 FILED
Monday, August 15, 2022SOU TEAS EXTENSION RECEIVED
Saturday, January 15, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 13, 2022SOU EXTENSION 3 GRANTED
Thursday, January 13, 2022SOU EXTENSION 3 FILED
Thursday, January 13, 2022SOU TEAS EXTENSION RECEIVED
Monday, August 30, 2021ASSIGNED TO EXAMINER
Tuesday, July 27, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 23, 2021SOU EXTENSION 2 GRANTED
Friday, July 23, 2021SOU EXTENSION 2 FILED
Friday, July 23, 2021SOU TEAS EXTENSION RECEIVED
Saturday, February 6, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 4, 2021SOU EXTENSION 1 GRANTED
Thursday, February 4, 2021SOU EXTENSION 1 FILED
Thursday, February 4, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, August 25, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 30, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 30, 2020PUBLISHED FOR OPPOSITION
Wednesday, June 10, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, May 21, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 13, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 12, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 12, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, November 14, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, November 14, 2019NON-FINAL ACTION E-MAILED
Thursday, November 14, 2019NON-FINAL ACTION WRITTEN
Wednesday, November 6, 2019ASSIGNED TO EXAMINER
Monday, August 26, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 12, 2019NEW APPLICATION ENTERED

Related Keywords

abicomp fields information diseases medical pharmaceutical disorders research providing pharmaceuticals biopharmaceuticals